Evidence map›Paper›PMID 42211242›Full record

ArticleCase reports in veterinary medicine2026

Evaluation of a Young Dog for Escalating Aggression Toward Both Familiar and Unfamiliar People.

Lynn Honeckman

Abstract read
In one paragraph

Article in Case reports in veterinary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lynn HoneckmanVeterinary Behavior Solutions, Orlando, Florida, USA.ORCID https://orcid.org/0000-0002-9871-2043

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report describes the evaluation and successful multimodal treatment of severe, early-onset aggression in a juvenile dog. A 9-month-old spayed female Australian Shepherd presented with escalating aggressive behaviors toward familiar and unfamiliar people, including multiple bite incidents resulting in human injury. Aggression was observed across numerous contexts, including handling, play, resource guarding, visitor interactions, and encounters with people and dogs outside the home. Significant risk factors included early removal from the dam at 6 weeks of age, minimal early socialization, a history of chronic illness during early development, and later-discovered aggressive traits in both parents. Comprehensive medical evaluation, including repeated laboratory testing and neurological assessment, revealed no underlying medical abnormalities. Behavioral diagnoses included generalized anxiety, impulse-control aggression, fear-related aggression, possessive aggression, and socialization deficits. Prior to referral, behavioral issues were minimized by outside advisors, and no psychopharmacologic intervention had been attempted due to the dog's young age. By 9 months, the family was considering rehoming or behavioral euthanasia due to safety concerns and breakdown of the human-animal bond. Treatment consisted of an integrated plan incorporating environmental management, strict safety protocols, positive reinforcement-based behavior modification, and pharmacologic therapy with fluoxetine and gabapentin. Within 6 weeks, the family reported moderate improvement, with marked and sustained improvement following dose adjustments and continued behavior modification. By 14 weeks, aggressive incidents had substantially decreased, and after 1 year of therapy, bite behavior had resolved. Long-term follow-up demonstrated stable improvement, improved tolerance of veterinary handling through cooperative care training, and restoration of household safety and quality of life. This case highlights the importance of early recognition, comprehensive assessment, and timely use of combined behavioral and pharmacologic interventions in juvenile dogs with severe aggression, emphasizing that young age should not preclude appropriate treatment.

Identifiers

PMID42211242
PMCPMC13213711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.